ELDN Eledon Pharmaceuticals, Inc.

Fundamentals / CIK 0001404281 / USD

Eledon Pharmaceuticals, Inc. reported $106.6M in total assets and a net loss of $85.03M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ELDN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$109.0MFY 2016 Revenue: $0FY 2016 Net Income: -$5.66M2016FY 2017 Net Income: -$13.12M2017FY 2018 Net Income: -$14.06M2018FY 2019 Net Income: -$16.01M2019FY 2020 Net Income: -$22.81M2020FY 2021 Net Income: -$34.51M2021FY 2022 Net Income: -$87.97M2022FY 2023 Net Income: -$116.5M2023FY 2024 Net Income: -$36.18M2024FY 2025 Net Income: -$45.62M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- -- -- -- -- $0
Research & Development $66.27M $51.96M $30.31M $27.08M $23.73M $6.13M $8.13M $6.82M $2.02M $3.19M
Total Operating Expenses $83.25M $70.58M $43.00M $88.43M $36.87M $18.46M $16.05M $14.06M $13.12M $5.13M
Operating Income -- -- -$43.00M -$88.43M -$36.87M -$18.46M -$16.05M -$14.06M -$13.12M -$5.13M
EBITDA -- -- -- -- -- -$18.46M -$16.04M -$14.05M -$13.10M -$5.09M
Income Before Tax -$45.58M -$35.75M -$116.5M -$87.97M -$36.86M -$23.21M -$16.01M -$14.06M -$13.12M -$5.66M
Income Tax Expense $35K $431K $0 $0 -$2.35M -$404K -- -- -- $0
Net Income -$45.62M -$36.18M -$116.5M -$87.97M -$34.51M -$22.81M -$16.01M -$14.06M -$13.12M -$5.66M
Basic EPS -$0.52 -$0.66 -$4.73 -$6.16 -$2.33 -$15.72 -$24.42 -$28.06 -$372.34 -$398.24
Diluted EPS -$0.52 -$0.66 -$4.73 -$6.16 -$2.33 -$15.72 -$24.42 -$28.06 -$372.34 -$398.24
Basic Shares Outstanding 81.8M 48.5M 24.6M 14.3M 14.8M 1.5M 655.5K 500.7K 28.9K 2.4K
Diluted Shares Outstanding 81.8M 48.5M 24.6M 14.3M 14.8M 1.5M 655.5K 500.7K 28.9K 2.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $17.76M $18.23M $17.20M $17.49M $14.97M $20.28M $13.53M $17.93M
Total Operating Expenses $21.67M $22.87M $21.18M $21.48M $19.07M $24.73M $17.96M $24.70M
Operating Income -$21.67M -$22.87M -$21.18M -- -$19.07M -$24.73M -$17.96M --
Net Income -$3.93M -$31.63M -$39.02M -$10.45M -$17.46M -$11.22M -$6.50M -$44.62M
Basic EPS -$0.03 -$0.27 -$0.33 -- -$0.21 -$0.13 -$0.08 --
Diluted EPS -$0.03 -$0.27 -$0.33 -- -$0.21 -$0.13 -$0.08 --
Basic Shares Outstanding 114.7M 113.6M 112.4M -- 77.2M 77.2M 77.1M --
Diluted Shares Outstanding 114.7M 113.6M 112.4M -- 77.2M 77.2M 77.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $22.81M $20.55M $4.61M $56.41M $84.83M $114.2M $8.79M $12.97M $17.23M $1.10M
Short-Term Investments $110.5M $119.6M $46.49M $0 -- -- -- -- -- --
Cash & Short-Term Investments $133.3M $140.2M $51.10M $56.41M $84.83M $114.2M $8.79M $12.97M $17.23M $1.10M
Other Current Assets $11K $104K $90K $28K $34K $38K $54K $36K $18K $33K
Total Current Assets $135.7M $143.7M $56.13M $59.52M $88.35M $115.6M $9.97M $14.28M $19.00M $1.15M
Property, Plant & Equipment, Net -- -- -- -- -- -- $5.0K $14K $25K $31K
Goodwill -- -- $0 $0 $48.65M $48.65M -- $1.87M $1.87M --
Other Non-Current Assets $322K $363K $186K $150K $400K $383K $639K $869K -- $15K
Total Non-Current Assets $33.32M $33.67M $32.94M $33.27M $82.20M $81.56M $960K $2.75M $1.89M $46K
Total Assets $169.0M $177.4M $89.07M $92.79M $170.5M $197.2M $10.93M $17.03M $20.89M $1.20M
Accounts Payable $3.63M $5.83M $967K $2.20M $1.81M $1.37M $329K $689K $418K $338K
Total Current Liabilities $18.34M $11.58M $3.90M $6.47M $4.40M $2.48M $1.32M $2.53M -- $3.90M
Total Non-Current Liabilities $13.89M $47.69M $77.96M $2.13M $2.15M $4.11M $144K $0 -- $84K
Total Liabilities $32.23M $59.27M $81.86M $8.61M $6.55M $6.59M $1.47M $2.53M $1.44M $3.90M
Total Debt (incl. Leases) $641K $954K $383K $746K $769K $144K $324K -- -- --
Common Stock $75K $60K $24K $14K $14K $15K $1.0K $9.0K $7.0K $1.0K
Retained Earnings -$401.2M -$355.6M -$319.4M -$202.9M -$114.9M -$80.39M -$57.58M -$41.57M -$27.51M -$14.39M
Accumulated Other Comp. Income $24K $26K -- -- -- -- -- -- -- -$1.0K
Total Stockholders' Equity $81.08M $62.45M -$48.49M $84.18M $164.0M $190.6M $9.46M $14.49M $19.45M -$2.70M
Total Equity $81.08M $62.45M -$48.49M $84.18M $164.0M $190.6M $9.46M $14.49M $19.45M -$2.70M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $6.88M $6.80M $6.15M $22.81M $3.67M $5.74M $8.50M $20.55M
Short-Term Investments $62.79M $81.95M $104.9M $110.5M $89.73M $101.8M $116.4M $119.6M
Cash & Short-Term Investments $69.70M $88.80M $111.1M $133.3M $93.40M $107.6M $124.9M $140.2M
Other Current Assets $497K $382K $9.0K $11K $14K $10K $55K $104K
Total Current Assets $73.71M $93.09M $113.6M $135.7M $96.30M $111.4M $127.7M $143.7M
Other Non-Current Assets $185K $172K $177K $322K $476K $346K $354K $363K
Total Non-Current Assets $32.93M $33.00M $33.09M $33.32M $33.56M $33.51M $33.59M $33.67M
Total Assets $106.6M $126.1M $146.7M $169.0M $129.9M $144.9M $161.3M $177.4M
Accounts Payable $2.84M $3.21M $6.58M $3.63M $4.63M $5.83M $2.90M $5.83M
Total Current Liabilities $11.70M $11.79M $13.46M $18.34M $14.30M $13.72M $9.19M $11.58M
Total Non-Current Liabilities $25.12M $42.27M $32.75M $13.89M $24.51M $25.16M $37.54M $47.69M
Total Liabilities $36.83M $54.06M $46.21M $32.23M $38.80M $38.88M $46.73M $59.27M
Total Debt (incl. Leases) $376K $467K $555K $641K $722K $803K $880K $954K
Common Stock $82K $81K $76K $75K $60K $60K $60K $60K
Retained Earnings -$475.8M -$471.9M -$440.2M -$401.2M -$390.8M -$373.3M -$362.1M -$355.6M
Accumulated Other Comp. Income -$126K -$114K -$72K $24K $9.0K -$48K -$18K $26K
Total Stockholders' Equity $30.80M $33.01M $44.76M $81.08M $35.36M $50.33M $58.89M $62.45M
Total Equity $30.80M $33.01M $44.76M $81.08M $35.36M $50.33M $58.89M $62.45M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$45.62M -$36.18M -$116.5M -$87.97M -$34.51M -$22.81M -$16.01M -$14.06M -$13.12M -$5.66M
Depreciation & Amortization -- -- -- -- -- $5.0K $9.0K $11K $22K $35K
Stock-Based Compensation $10.45M $13.12M $6.54M $8.15M $7.90M $3.17M $1.31M $1.54M $579K $171K
Change in Payables -- -- -- -- -- -- -- -- -- -$778K
Operating Cash Flow -$62.34M -$47.27M -$39.53M -$28.42M -$28.91M -$15.21M -$13.86M -$11.89M -$14.94M -$4.92M
Capital Expenditure -- -- -- -- -- -- -- -- -- -$9.0K
Free Cash Flow -- -- -- -- -- -- -- -- -- -$4.93M
Purchases of Investments -$161.1M -$156.1M -$78.29M -- -- -- -- -- -- -$500K
Investing Cash Flow $10.79M -$70.31M -$45.29M -- -- $11.04M -- -- $23.26M $1.0K
Common Stock Issued -- -- -- -- -- $9.00M $9.68M $7.49M $4.75M --
Financing Cash Flow $53.81M $133.5M $33.02M -- -$449K $109.6M $9.68M $7.56M $7.87M $2.93M
Net Change in Cash $2.26M $15.94M -$51.80M -$28.42M -$29.36M $105.4M -$4.18M -$4.33M $16.19M -$1.99M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.93M -$31.63M -$39.02M -$10.45M -$17.46M -$11.22M -$6.50M -$44.62M
Stock-Based Compensation $1.92M $3.15M $2.20M $2.46M $2.43M $2.69M $2.86M $6.58M
Operating Cash Flow -$18.98M -$22.68M -$22.61M -$14.09M -$14.48M -$17.71M -$16.06M -$18.99M
Purchases of Investments -$9.37M -$16.26M -$43.12M -$69.22M -$32.66M -$27.40M -$31.85M -$72.78M
Investing Cash Flow $19.33M $23.24M $5.96M -$20.46M $12.40M $14.96M $3.89M -$47.38M
Financing Cash Flow -- -- -- $53.69M $0 $0 $115K $80.17M
Net Change in Cash $79K $651K -$16.66M $19.14M -$2.07M -$2.75M -$12.05M $13.80M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -56.3% -57.9% -- -104.5% -21.0% -12.0% -169.2% -97.1% -67.4% --
Return on Assets (ROA) -27.0% -20.4% -130.8% -94.8% -20.2% -11.6% -146.5% -82.6% -62.8% -472.8%
Current Ratio 7.40x 12.42x 14.41x 9.19x 20.07x 46.57x 7.54x 5.63x -- 0.30x
Quick Ratio 7.27x 12.11x 13.12x 8.71x 19.28x 45.99x 6.65x 5.12x -- 0.28x
Debt to Equity 0.01x 0.02x -- 0.01x 0.00x 0.00x 0.03x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -276.1% -298.6% -174.6% -56.3% -225.6% 29.1% -32.3% -57.9%
Return on Assets (ROA) -79.7% -78.2% -53.3% -27.0% -61.4% 10.1% -11.8% -20.4%
Current Ratio 6.30x 7.90x 8.44x 7.40x 6.74x 8.12x 13.91x 12.42x
Quick Ratio 5.96x 7.53x 8.26x 7.27x 6.53x 7.84x 13.60x 12.11x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.02x 0.02x 0.01x 0.02x
Net Income Growth (YoY) -- -- -- -- -122.7% -- -- --
EPS Growth (YoY) -- -- -- -- -120.0% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001404281) · from December 31, 2012 Data through September 30, 2026 · synced Nov 20, 2026, 05:43 UTC · Open in terminal